Integra LifeSciences Holdings Corporation Revenue and Competitors

Location

$350M

Total Funding

Estimated Revenue & Valuation

  • Integra LifeSciences Holdings Corporation's estimated annual revenue is currently $1.5B per year.(i)
  • Integra LifeSciences Holdings Corporation's estimated revenue per employee is $357,226
  • Integra LifeSciences Holdings Corporation's total funding is $350M.
  • Integra LifeSciences Holdings Corporation's current valuation is $5.8B. (January 2022)

Employee Data

  • Integra LifeSciences Holdings Corporation has 4283 Employees.(i)
  • Integra LifeSciences Holdings Corporation grew their employee count by -2% last year.

Integra LifeSciences Holdings Corporation's People

NameTitleEmail/Phone
1
Corporate VP & Chief Information OfficerReveal Email/Phone
2
Chief ScientistReveal Email/Phone
3
Chief Medical Officer and Corporate VPReveal Email/Phone
4
Corporate VP, Chief Quality OfficerReveal Email/Phone
5
Corporate VP & Chief Regulatory OfficerReveal Email/Phone
6
Regulatory International (OUS) VP Integra LifeSciencesReveal Email/Phone
7
Corporate VP & Chief Regulatory OfficerReveal Email/Phone
8
Corporate VP, Global Operations & Supply ChainReveal Email/Phone
9
Corporate VP, Business DevelopmentReveal Email/Phone
10
Chief Engineer / BoilersReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.8M3111%N/AN/A
#2
$12.3M49-4%N/AN/A
#3
$15.1M607%N/AN/A
#4
$8.8M35-8%N/AN/A
#5
$3M129%N/AN/A
#6
$300.4M11973%N/AN/A
#7
$311.7M12422%N/AN/A
#8
$0.3M1-96%N/AN/A
#9
$8.3M333%N/AN/A
#10
$13.6M548%N/AN/A
Add Company

What Is Integra LifeSciences Holdings Corporation?

Integra LifeSciences Holdings Corporation develops, manufactures and markets medical devices, implants and biomaterials. The Company's operations consist of Integra NeuroSciences, which is a provider of implants, devices and monitors used in neurosurgery, neurotrauma and related critical care, and Integra LifeSciences, which develops and manufactures a variety of medical products and devices, including products based on the Company's proprietary tissue regeneration technology that are used to treat soft tissue and orthopedic conditions. The Company manufactures and markets a multi-line offering of neurosurgical devices used for brain and spine injuries. The Integra LifeSciences Division develops and manufactures tissue regeneration products and surgical products that are primarily sold outside of neurosurgery and neurotrauma. Many of the products of Integra LifeSciences are built on the Company's expertise in resorbable collagen products.

keywords:N/A

$350M

Total Funding

4283

Number of Employees

$1.5B

Revenue (est)

-2%

Employee Growth %

$5.8B

Valuation

N/A

Accelerator

Integra LifeSciences Holdings Corporation News

2022-04-20 - Q2 2022 EPS Estimates for Integra LifeSciences Holdings Co ...

In the last three months, insiders have sold 231,268 shares of company stock worth $15,050,939. 4.20% of the stock is owned by corporate...

2022-04-19 - Integra LifeSciences Holdings Corporation (IART) CEO Jan De Witte on Q1 2022 Results - Earnings Call Transcript

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2022 Earnings Conference Call April 27, 2022 8:30 AM ET. Company Participants.

2022-04-17 - Integra LifeSciences Reports First Quarter 2022 Financial ...

PRINCETON, N.J., April 27, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical...

2021-04-28 - INTEGRA LIFESCIENCES HOLDINGS CORPORATION Integra LifeSciences Reports First Quarter 2021 Financial Results

PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2021. First Quarter 2021 Financial Summary Reported revenues were $3 ...

2021-02-18 - Integra LifeSciences Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides 2021 Financial Guidance

PRINCETON, N.J., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full-year ended December 31, 2020, consistent with its preliminary revenue results announced on January 14, 2021. Fourth Quarte ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1135.8M45072%N/A
#2
$1567.6M5313-1%$600.1M
#3
$1130.9M55718%N/A
#4
$1149.9M5744-8%N/A
#5
$21970M57836%N/A